Menu
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should Value Investors Buy This Healthcare Stock?


Value investing is a rather popular investing strategy. Seeing as almost everyone enjoys buying great products at discounted prices, it isn't surprising that we would also like to get good deals on stocks.

But investors need to be careful that they aren't buying junk companies for their portfolios. Health insurer (NYSE: CI), is far from junk: Having turned a $5,000 investment made 10 years ago into nearly $20,000 with dividends reinvested today, the proof is in the pudding. Put into perspective, that is much better than the $16,000 that the same investment amount in the S 500 index would now be worth with dividends reinvested.

But are shares of Cigna currently a buy for value investors? Let's assess the company's fundamentals and valuation.

Continue reading


Source Fool.com

Cigna Corp. Stock

€316.50
1.190%
There is an upward development for Cigna Corp. compared to yesterday, with an increase of €3.75 (1.190%).
With 21 Buy predictions and not a single Sell prediction Cigna Corp. is an absolute favorite of our community.
As a result the target price of 356 € shows a slightly positive potential of 12.48% compared to the current price of 316.5 € for Cigna Corp..
Like: 0
CI
Share

Comments